24/7 BIOPHARMA - issue 1 / October 2024

CONTENTS

SUNRESIN NEW MATERIALS 66 Innovation in mAb

52 INTERVIEW

urification using affinity chromatography resins based on proprietary rProtein A

SYNGENE INTERNATIONAL 70 The role of quality management in modern CRDMOs

ANDREAS RAABE CEO Adragos Pharma Chairman YPO Board Member MedTech space

DIGITAL VERSION

RENAISSANCE LAKEWOOD 56 The road to commercializing nasal

drug products: Setting up for success with R&D and clinical manufacturing

WOMEN IN SCIENCE

60

BONUS FEATURES from page 73

TATIANA ROSENSTOCK Principal Scientist in in-vitro Neuroscience Sygnature Discovery

3

TWENTYFOURSEVENBIOPHARMA Issue 1 / October 2024